Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer Using Simultaneous Integrated Boost and Urethral-Sparing IMRT Planning

NCT02470897 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT02470897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02470897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer Using Simultaneous Integrated Boost and Urethral-Sparing IMRT Planning
Lead sponsor
University of Wisconsin, Madison
Phase
Not applicable
Overall status
Completed
Start date
July 24, 2015
Completion date
August 18, 2025
Enrollment
115 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stage i prostate adenocarcinoma, stage ii prostate adenocarcinoma